Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Maria Geretti

Showing results (81-90 of 175) with videos related to

Pageof 18
Sort By:
The Journal of Antimicrobial Chemotherapy|December 28, 2023
A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistanceAdam Abdullahi, Ana Garcia Diaz, Olga Mafotsing Fopoussi, et al.
The Journal of Antimicrobial Chemotherapy|December 14, 2018
Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistanceAnna Maria Geretti, Ellen White, Chloe Orkin, et al.
Sexually Transmitted Infections|May 21, 2026
Revisiting gonorrhoea prevention in the era of resistance and biomedical interventionsJustyna D Kowalska, Jean-Michel Molina, Ismael Maatouk, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2019
An apparent paradox: resistance mutations in HIV-1 DNA predict improved virological responses to antiretroviral therapyAnna Maria Geretti, Adam Abdullahi, Olga Mafotsing Fopoussi, et al.
Scientific Reports|October 19, 2018
Point-of-Care Screening for a Current Hepatitis C Virus Infection: Influence on Uptake of a Concomitant Offer of HIV ScreeningAnna Maria Geretti, Harrison Austin, Giovanni Villa, et al.
Journal of Hepatology|April 27, 2020
The global prevalence of hepatitis D virus infection: Systematic review and meta-analysisAlexander J Stockdale, Benno Kreuels, Marc Y R Henrion, et al.
Life (Basel, Switzerland)|December 24, 2021
Measuring Proviral HIV-1 DNA: Hurdles and Improvements to an Assay Monitoring Integration Events Utilising Human <i>Alu</i> Repeat SequencesEva Malatinkova, Jordan Thomas, Ward De Spiegelaere, et al.
European Journal of Pediatrics|January 6, 2004
Disseminated neonatal herpes simplex virus (HSV) type 2 infection diagnosed by HSV DNA detection in blood and successfully managed by liver transplantationMary Twagira, Nedim Hadzic, Melvyn Smith, et al.
Journal of the International AIDS Society|March 9, 2010
Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapyPhilippa J Easterbrook, Mel Smith, Jane Mullen, et al.
HIV Medicine|July 17, 2025
CROI 2025 BHIVA working group summaryCaroline A Sabin, Tristan J Barber, Laura Waters, et al.
Pageof 18

Showing results (81-90 of 175) with videos related to

Sort By:
Pageof 18
The Journal of Antimicrobial Chemotherapy|December 28, 2023
A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistanceAdam Abdullahi, Ana Garcia Diaz, Olga Mafotsing Fopoussi, et al.
The Journal of Antimicrobial Chemotherapy|December 14, 2018
Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistanceAnna Maria Geretti, Ellen White, Chloe Orkin, et al.
Sexually Transmitted Infections|May 21, 2026
Revisiting gonorrhoea prevention in the era of resistance and biomedical interventionsJustyna D Kowalska, Jean-Michel Molina, Ismael Maatouk, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2019
An apparent paradox: resistance mutations in HIV-1 DNA predict improved virological responses to antiretroviral therapyAnna Maria Geretti, Adam Abdullahi, Olga Mafotsing Fopoussi, et al.
Scientific Reports|October 19, 2018
Point-of-Care Screening for a Current Hepatitis C Virus Infection: Influence on Uptake of a Concomitant Offer of HIV ScreeningAnna Maria Geretti, Harrison Austin, Giovanni Villa, et al.
Journal of Hepatology|April 27, 2020
The global prevalence of hepatitis D virus infection: Systematic review and meta-analysisAlexander J Stockdale, Benno Kreuels, Marc Y R Henrion, et al.
Life (Basel, Switzerland)|December 24, 2021
Measuring Proviral HIV-1 DNA: Hurdles and Improvements to an Assay Monitoring Integration Events Utilising Human <i>Alu</i> Repeat SequencesEva Malatinkova, Jordan Thomas, Ward De Spiegelaere, et al.
European Journal of Pediatrics|January 6, 2004
Disseminated neonatal herpes simplex virus (HSV) type 2 infection diagnosed by HSV DNA detection in blood and successfully managed by liver transplantationMary Twagira, Nedim Hadzic, Melvyn Smith, et al.
Journal of the International AIDS Society|March 9, 2010
Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapyPhilippa J Easterbrook, Mel Smith, Jane Mullen, et al.
HIV Medicine|July 17, 2025
CROI 2025 BHIVA working group summaryCaroline A Sabin, Tristan J Barber, Laura Waters, et al.
Pageof 18